Published in Age Ageing on March 01, 1996
Vision impairment and hearing loss among community-dwelling older Americans: implications for health and functioning. Am J Public Health (2004) 2.74
Effects of age on auditory and cognitive processing: implications for hearing aid fitting and audiologic rehabilitation. Trends Amplif (2006) 1.88
Deafness and mortality: analyses of linked data from the National Health Interview Survey and National Death Index. Public Health Rep (1999) 1.61
Prevalence of concurrent hearing and visual impairment in US adults: The National Health Interview Survey, 1997-2002. Am J Public Health (2005) 1.52
Hearing in middle age: a population snapshot of 40- to 69-year olds in the United Kingdom. Ear Hear (2014) 1.13
Cochlear implantation in older adults. Medicine (Baltimore) (2012) 1.10
Determinants of hearing aid acquisition in older adults. Am J Public Health (2011) 1.08
Sensory impairment among older US workers. Am J Public Health (2009) 1.04
The non-use of hearing aids in people aged 75 years and over in the city of Kuopio in Finland. Eur Arch Otorhinolaryngol (2004) 1.03
Dual sensory impairment in older adults increases the risk of mortality: a population-based study. PLoS One (2013) 1.00
Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. Qual Life Res (2007) 0.99
Health-related quality of life following blind rehabilitation. Qual Life Res (2008) 0.97
Hearing, mobility, and pain predict mortality: a longitudinal population-based study. J Clin Epidemiol (2012) 0.95
Multisensory integration across the senses in young and old adults. Brain Res (2011) 0.88
Multisensory integration, aging, and the sound-induced flash illusion. Psychol Aging (2013) 0.87
Satisfaction with Hearing Aids among Aged Patients with Different Degrees of Hearing Loss and Length of Daily Use. J Audiol Otol (2015) 0.81
Vision-enhancing interventions in nursing home residents and their short-term effect on physical and cognitive function. J Am Geriatr Soc (2008) 0.80
Quality of life after intervention with a cochlear implant or hearing aid. Laryngoscope (2016) 0.80
The need for improved detection and management of adult-onset hearing loss in australia. Int J Otolaryngol (2013) 0.79
RELATIONSHIP OF GAIT AND COGNITION IN THE ELDERLY. Curr Transl Geriatr Exp Gerontol Rep (2013) 0.79
Hearing Aid Use and Associated Factors in South Korea. Medicine (Baltimore) (2015) 0.79
Socioeconomic Position and Health-Seeking Behavior for Hearing Loss Among Older Adults in England. J Gerontol B Psychol Sci Soc Sci (2014) 0.78
Evaluation of the Hearing Aid Rehabilitation Questionnaire in Dutch: Examination of its Psychometric Properties and Potential Use as a Screening Instrument. Audiol Res (2013) 0.77
Sex-specific predictors of hearing-aid use in older persons: The age, gene/environment susceptibility - Reykjavik study. Int J Audiol (2015) 0.75
Hearing Loss and Quality of Life (QOL) among Human Immunodeficiency Virus (HIV)-Infected and Uninfected Adults. J AIDS Clin Res (2016) 0.75
Neural Alterations in Acquired Age-Related Hearing Loss. Front Psychol (2016) 0.75
Physiology and psychology of vision and its disorders: a review. Med Hypothesis Discov Innov Ophthalmol (2014) 0.75
How sociodemographic and hearing related factors were associated with use of hearing aid in a population-based study: The HUNT Study. BMC Ear Nose Throat Disord (2016) 0.75
Aging, Spatial Disparity, and the Sound-Induced Flash Illusion. PLoS One (2015) 0.75
Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc (2000) 3.59
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial. Aging Ment Health (2010) 2.46
Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol (1998) 2.38
Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc (1993) 2.02
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J (1998) 1.86
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology (1999) 1.78
Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol (1996) 1.74
Object and action naming in Alzheimer's disease and frontotemporal dementia [see comment]. Neurology (1998) 1.71
Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol (1996) 1.60
Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A (1998) 1.58
Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology (2001) 1.54
Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci (2001) 1.52
Depressive symptoms of Alzheimer caregivers are mainly due to personal rather than patient factors. Int J Geriatr Psychiatry (1998) 1.51
Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients. J Am Geriatr Soc (1996) 1.48
Elevated glutamate in the cerebrospinal fluid of patients with HIV dementia. JAMA (1997) 1.41
Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord (1999) 1.37
Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology (1996) 1.36
Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke. J Neurosci Res (1984) 1.35
Association between depressive symptoms and mortality in elderly people. Arch Intern Med (2001) 1.35
Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol (1999) 1.32
Contrasting results between caregiver's report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver's personal characteristics. J Am Geriatr Soc (1999) 1.31
APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology (1999) 1.30
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29
Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients. Intensive Care Med (2008) 1.28
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27
Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 1.26
Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab (1999) 1.23
Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology. Neuropharmacology (1974) 1.23
Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. Arch Gerontol Geriatr (2007) 1.20
Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci (1978) 1.17
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry (2000) 1.16
Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry (2000) 1.16
Neuropsychological heterogeneity in mild Alzheimer's disease. Dementia (1994) 1.13
PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death Differ (2011) 1.11
Sensory impairments and mortality in an elderly community population: a six-year follow-up study. Age Ageing (1995) 1.07
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 1.06
Addendum to 'Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial' (Raglio et al., 2010). Aging Ment Health (2012) 1.06
Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol (1978) 1.05
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology (1999) 1.05
Carboplatin toxic effects on the peripheral nervous system of the rat. Ann Oncol (1998) 1.05
Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia (1995) 1.05
Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry (1996) 1.04
The effect of chronic diseases on physical function. Comparison between activities of daily living scales and the Physical Performance Test. Age Ageing (1997) 1.03
Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene. Neurology (2000) 1.01
Principal lifetime occupation and sleep quality in the elderly. Gerontology (1996) 1.00
LEIPAD, an internationally applicable instrument to assess quality of life in the elderly. Behav Med (1998) 1.00
Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol (1996) 1.00
Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology (1993) 0.99
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology (2001) 0.98
Italian community norms for the Brief Symptom Inventory in the elderly. Br J Clin Psychol (1993) 0.98
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia (1994) 0.96
Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res (1977) 0.96
Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ (2009) 0.96
Physical Performance Test and Activities of Daily Living scales in the assessment of health status in elderly people. J Am Geriatr Soc (1993) 0.95
Dental status, quality of life, and mortality in an older community population: a multivariate approach. J Am Geriatr Soc (1997) 0.95
The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol (1997) 0.95
Consensus and variations in opinions on delirium care: a survey of European delirium specialists. Int Psychogeriatr (2013) 0.94
Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci Lett (1995) 0.93
Community care for patients with Alzheimer's disease and non-demented elderly people: use and satisfaction with services and unmet needs in family caregivers. Int J Geriatr Psychiatry (1999) 0.93
Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol (1993) 0.92
Effect of transcutaneous electrotherapy on CSF beta-endorphin content in patients without pain problems. Pain (1981) 0.92
Clinical characteristics and risk factors of delirium in demented and not demented elderly medical inpatients. J Nutr Health Aging (2006) 0.92
Music, music therapy and dementia: a review of literature and the recommendations of the Italian Psychogeriatric Association. Maturitas (2012) 0.92
Vinblastine and vincristine: a study of their action on tissue concentrations of epinephrine, norephinephrine and acetylcholine. Neuropharmacology (1973) 0.91
Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders. Br J Clin Pract Suppl (1984) 0.91
Insight in dementia: when does it occur? Evidence for a nonlinear relationship between insight and cognitive status. J Gerontol B Psychol Sci Soc Sci (1999) 0.90
Visual and spatial perception in the early phase of Alzheimer's disease. Neuropsychology (1998) 0.90
The metabolism of cyclic-3'-5'-adenosine monophosphate (cAMP) in diseased muscle. J Neurol (1975) 0.90
Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex. J Neurochem (1996) 0.90
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases. Neurol Sci (2004) 0.90
Usefulness of simple measures of temporal lobe atrophy in probable Alzheimer's disease. Dementia (1996) 0.89
Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci Lett (1997) 0.89
The Mini-Mental State Examination in Alzheimer's disease and multi-infarct dementia. Int Psychogeriatr (1996) 0.89
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. Acta Neurol Scand (1997) 0.89
Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res (1998) 0.88
The Italian version of the pain assessment in advanced dementia (PAINAD) scale. Arch Gerontol Geriatr (2006) 0.88
Influence of dental status on dietary intake and survival in community-dwelling elderly subjects. Age Ageing (1997) 0.88
Depression in carers of elderly people living at home. Carers' characteristics could be risk factors. BMJ (1996) 0.88
A nutritional index predicting mortality in the nursing home. J Am Geriatr Soc (1994) 0.88
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicol Lett (2000) 0.88
Serum cholesterol levels as a measure of frailty in elderly patients. Exp Aging Res (1998) 0.88
Cognition and the perception of physical symptoms in the community-dwelling elderly. Behav Med (1999) 0.88
The Bedford Alzheimer Nursing Severity scale for the severely demented: validation study. Alzheimer Dis Assoc Disord (1997) 0.88
Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. J Neurochem (1985) 0.88
Reboxetine and hyponatremia. N Engl J Med (2000) 0.87
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. Age Ageing (1998) 0.87
Coma in a patient with Alzheimer's disease taking low dose trazodone and gingko biloba. J Neurol Neurosurg Psychiatry (2000) 0.87
Nutritional intake, socioeconomic conditions, and health status in a large elderly population. J Am Geriatr Soc (1990) 0.87
Effects of bromocriptine on central dopaminergic receptors. Life Sci (1976) 0.86
Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology (1993) 0.86
Reality orientation therapy to delay outcomes of progression in patients with dementia. A retrospective study. Clin Rehabil (2001) 0.86
Plasma prolactin concentrations in lead exposed workers. J Environ Pathol Toxicol Oncol (1987) 0.86